Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $6,097,304 were sold by Sabag Mark on May 08 ’25. At $18.04 per share, Sabag Mark sold 337,915 shares. The insider’s holdings dropped to 150,996 shares worth approximately $2.74 million following the completion of this transaction.
Also, Sabag Mark purchased 337,915 shares, netting a total of over 6,097,324 in proceeds.
Before that, Daniell Richard had sold 70,961 shares from its account. In a trade valued at $1,128,642, the Exec. VP, European Commercial traded Teva- Pharmaceutical Industries Ltd. ADR shares for $15.91 each. Upon closing the transaction, the insider’s holdings decreased to 70,961 shares, worth approximately $0.88 million.
As published in their initiating research note from Truist on May 28, 2025, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been a Buy and the price target has been revised to $25. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid May. As of July 10, 2024, Argus has increased its “Hold” rating to a “Buy” for TEVA. Earlier on March 08, 2024, JP Morgan upgraded its rating. Their new recommendation was “a Neutral” for TEVA stock which previously was a “an Underweight”.
Analyzing TEVA Stock Performance
During the last five days, there has been a surge of approximately 8.16%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have dropped approximately -17.65%. Shares of the company reached a 52-week high of $22.40 on 01/28/25 and a 52-week low of $12.47 on 04/10/25.
Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
According to the 24-hour chart, there is a support level at 17.86, which, if violated, would cause prices to drop to 17.58. In the upper region, resistance lies at 18.29. The next price resistance is at 18.44. RSI (Relative Strength Index) is 65.59 on the 14-day chart, showing neutral technical sentiment.
